260391-64-8Relevant articles and documents
PYRROLOBENZODIAZEPINE CONJUGATES
-
Page/Page column 67; 68, (2020/05/21)
A compound of formula (I) and salts and solvates thereof, wherein RL is a linker for connection to a cell binding agent, which is formula (IIa) wherein Q is a tripeptide residue of formula (A), where x is 1 or 2, -C(=O)-Qx-NH- is a dipeptide residue; X is: formula (B), where a = 0 to 5, b = 0 to 16, c = 0 or 1, d = 0 to 5; and GL is a linker for connecting to a Ligand Unit.
Design and synthesis of novel pyrrolobenzodiazepine (PBD) prodrugs for ADEPT and GDEPT
Sagnou, Marina J.,Howard, Philip W.,Gregson, Stephen J.,Eno-Amooquaye, Ebun,Burke, Philip J.,Thurston, David E.
, p. 2083 - 2086 (2007/10/03)
Three N10-(4-nitrobenzyl)carbamate-protected PBD prodrugs (9a, 9b and 15) have been synthesized and evaluated for potential use in nitroreductase-based ADEPT and GDEPT therapies. An approximately 100-fold activation was observed for the DC-81 prodrug 9a.